Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
Peer Reviewed
See detailNo accelerated rate of protein evolution in male-biased Drosophila pseudoobscura genes.
Metta, Muralidhar ULg; Gudavalli, Rambabu; Gibert, Jean-Michel et al

in Genetics (2006), 174(1), 411-20

Sexually dimorphic traits are often subject to diversifying selection. Genes with a male-biased gene expression also are probably affected by sexual selection and have a high rate of protein evolution. We ... [more ▼]

Sexually dimorphic traits are often subject to diversifying selection. Genes with a male-biased gene expression also are probably affected by sexual selection and have a high rate of protein evolution. We used SAGE to measure sex-biased gene expression in Drosophila pseudoobscura. Consistent with previous results from D. melanogaster, a larger number of genes were male biased (402 genes) than female biased (138 genes). About 34% of the genes changed the sex-related expression pattern between D. melanogaster and D. pseudoobscura. Combining gene expression with protein divergence between both species, we observed a striking difference in the rate of evolution for genes with a male-biased gene expression in one species only. Contrary to expectations, D. pseudoobscura genes in this category showed no accelerated rate of protein evolution, while D. melanogaster genes did. If sexual selection is driving molecular evolution of male-biased genes, our data imply a radically different selection regime in D. pseudoobscura. [less ▲]

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailNo association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease
Willot, S.; Vermeire, S.; Ohresser, M. et al

in Pharmacogenetics and Genomics (2006), 16(1), 37-42

We recently showed an association between the FCGR3A V/F polymorphism and the biological response [assessed on the basis of a C-reactive protein (CRP) concentration decrease] to infliximab in Crohn's ... [more ▼]

We recently showed an association between the FCGR3A V/F polymorphism and the biological response [assessed on the basis of a C-reactive protein (CRP) concentration decrease] to infliximab in Crohn's disease. The CRP and FCGR3A genes are located on the same 1q23 locus. The present study aimed: 0) to exclude a linkage disequilibrium (LD) between the two genes and 00 to study the association between CRP polymorphisms and the response to infliximab, particularly the decrease in CRP after treatment, in Crohn's disease patients. FCGR3A (V/F) polymorphism and three CRP polymorphisms (- 717G/A, 1444C/T, CRP 4A/G) were determined in 206 healthy blood donors and 189 Crohn's disease patients who had received infliximab for either refractory luminal or fistulizing Crohn's disease. Clinical response was defined as complete, partial or absent according to the same definition as in controlled trials. The biological response was defined on the basis of CRP decrease. There was no LID between CRP and FCGR3A in healthy donors or Crohn's disease patients. CRP polymorphisms had no impact on CRP decrease after infliximab. The proportions of Crohn's disease having a positive clinical or biological response were not statistically different among the various genotypes of CRP polymorphisms. There was no LD between CRP and FCGR3A polymorphisms. CRP polymorphisms were not associated with the response to infliximab in Crohn's disease. Pharmacogenetics and Genomics 16:37-42. (c) 2006 Lippincott Williams [less ▲]

Detailed reference viewed: 38 (1 ULg)
Peer Reviewed
See detailNo delay in the court – divorce in France and Belgium
Bastard, Benoit; Delvaux, David ULg; Schoenaers, Frédéric ULg et al

Conference (2012, July)

Detailed reference viewed: 18 (2 ULg)
Full Text
See detailNo earthquake with characteristic slip on the North Anatolian Fault, Turkey
Hubert, Aurelia ULg; Fraser, J.; Drab, L. et al

in Geophysical Research Abstracts (2009, April)

Detailed reference viewed: 9 (1 ULg)
Full Text
Peer Reviewed
See detailNo effect of eletriptan administration during the aura phase of migraine
Olesen, J.; Diener, H. C.; Schoenen, Jean ULg et al

in European Journal of Neurology (2004), 11(10), 671-677

Migraine aura is a warning sign readily recognized by patients. From the onset of aura it takes 30-60 min before the headache phase starts. Administration of acute medication during aura should provide ... [more ▼]

Migraine aura is a warning sign readily recognized by patients. From the onset of aura it takes 30-60 min before the headache phase starts. Administration of acute medication during aura should provide sufficient time to achieve therapeutic plasma levels, counteracting the headache. To test this hypothesis we evaluated the efficacy of eletriptan 80 mg taken during aura. Patients met International Headache Society diagnostic criteria for migraine with aura, with an attack frequency of at least one per month and with aura occurring in >50% of recent attacks. Of 123 patients randomized, 87 (71%) were treated with a double-blind, one attack, during the aura phase before headache, dose of either eletriptan 80 mg (n = 43; 74% female; mean age, 40 years), or placebo (n = 44; 82% female; mean age, 40 years). The primary outcome measure was the proportion of patients not developing moderate-to-severe headache within 6 h post-dose. There was no significant difference in the proportion of patients developing moderate-to-severe headache on eletriptan (61%) versus placebo (46%). Eletriptan was well tolerated and did not prolong the aura phase. Typical transient triptan adverse events were observed; most were mild-to-moderate in intensity. This study confirms the findings of two studies showing that triptans are ineffective but safe when given during the migraine aura phrase. [less ▲]

Detailed reference viewed: 18 (0 ULg)
Full Text
Peer Reviewed
See detailNo effect of parity on concentrations of bovine pregnancy associated glycoprotein (PAG) measurement by radioimmunoassay.
Ayad, A.; Melo de Sousa, Noelita ULg; Iguer-Ouada, M. et al

in Reproduction in Domestic Animals (2008), 43(Suppl 5), 90

Detailed reference viewed: 8 (1 ULg)
Full Text
Peer Reviewed
See detailNo efficiency of the lateral system on nocturnal feeding in the European sea bass (Dicentrarchus labrax L.)
Faucher, Karine ULg; Dutto, Gilbert; Covès, Denis et al

in Aquaculture (2006), 252(2-4), 462-475

In order to evaluate the effect and consequence of lateral system inactivation on fish nocturnal feeding, the differential growth of groups of European sea bass maintained in different rearing conditions ... [more ▼]

In order to evaluate the effect and consequence of lateral system inactivation on fish nocturnal feeding, the differential growth of groups of European sea bass maintained in different rearing conditions were compared. Whereas some fish with intact lateral system (placebo fish) were placed under a photoperiod of 12-L: 12-D, other placebo fish were kept in the dark. In the same way, fish deprived of lateral system by section of their lateral system nerves and antibiotic treatment were placed under a photoperiod of 12-L :12-D and the others in the dark. For each of these four rearing conditions, two sets of experiment were realized. Percent mortality, feed rhythm, averaged daily feed demand, specific growth rate and feed efficiency were compared among these four groups of fish. After four months of experiment, results revealed that, under a photoperiod of 12-L: 12-D, fish showed a diurnal feed rhythm whereas no rhythm appeared in fish kept in the dark. In addition, as reported by other authors, the average daily feed demand, the quantity of ingested food and specific growth rate were greater in fish maintained under a photoperiod of 12-L :12-D than those kept in the dark. The fish lateral system inactivation did not affect mortality, feed intake, specific growth rate or feed efficiency. These results demonstrated that lateral system is not the major sensory organ leading to European sea bass nocturnal feeding; chemoreception system undoubtedly taking over. If the olfactory system explains equal feed intake between placebo and treated fish, the greater specific growth rate in treated than in placebo fish indicates the action of another mechanism, such as a "booster effect" of antibiotics used for lateral system inactivation on fish. [less ▲]

Detailed reference viewed: 22 (2 ULg)
Full Text
Peer Reviewed
See detailNo evidence of age-related increases in unconscious plagiarism during free recall.
Perfect, Timothy J.; Defeldre, Anne-Catherine; Elliman, Rachel et al

in Memory (2011)

In 3 experiments younger and older participants took part in a group generation task prior to a delayed recall task. In each, participants were required to recall the ideas that they had generated ... [more ▼]

In 3 experiments younger and older participants took part in a group generation task prior to a delayed recall task. In each, participants were required to recall the ideas that they had generated, avoiding plagiarism errors. All studies showed the same pattern: older adults did not plagiarise their partners any more than younger adults did. However, older adults were more likely than younger adults to intrude with entirely novel items not previously generated by anyone. These findings stand in opposition to the single previous demonstration of age-related increases in plagiarism during recall. [less ▲]

Detailed reference viewed: 28 (5 ULg)
Full Text
Peer Reviewed
See detailNo evidence of human papillomavirus DNA in breast carcinoma in Tunisian patients
Hachana, Mohamed Ridha ULg; Ziadi, Sonia; Amara, Khaled et al

in Breast (Edinburgh, Scotland ) (2010), 19(6), 541-544

Detailed reference viewed: 7 (2 ULg)
Full Text
Peer Reviewed
See detailNo Increase in Plasma Histamine During Paf-Induced Airway Obstruction in Allergic Asthmatics
Louis, Renaud ULg; Bury, Thierry ULg; Corhay, Jean-Louis ULg et al

in CHEST (1993), 104(3), 806-10

To investigate the possible role of mast cell or basophil histamine release in mediating platelet-activating factor (PAF) airway obstruction, we studied the effect of inhaled PAF (30 micrograms, single ... [more ▼]

To investigate the possible role of mast cell or basophil histamine release in mediating platelet-activating factor (PAF) airway obstruction, we studied the effect of inhaled PAF (30 micrograms, single dose) on plasma histamine, bronchial caliber, and leukocyte and platelet counts in six patients with mild or moderate allergic asthma (mean age, 27 +/- 1.3 years; mean FEV1, 95 +/- 5 percent of predicted; mean PC20 methacholine, 1.46 +/- 0.36 mg/ml). Specific conductance (SGaw) FEV1, FEF25-75 percent, differential leukocyte and platelet counts, and plasma histamine (radioimmunoassay) were measured before and 5, 10, 15, and 20 min after PAF inhalation. Mean basal plasma histamine level was 0.28 +/- 0.04 ng/ml. Inhalation of PAF caused a fall in SGaw peaking at 5 min (43 +/- 9 percent) and a fall in FEV1 and FEF25-75 peaking at 10 min (19 +/- 10 percent and 30 +/- 13 percent, respectively). There was also a rapid and transient fall in circulating neutrophils at 5 min (from 3,096 +/- 204/mm3 to 2,551 +/- 158/mm3, p < 0.05) followed by a rebound neutrophilia. In contrast, plasma histamine level did not change significantly at any time measured. Conversely in the same asthmatics, a rapid rise in plasma histamine level (from 0.29 +/- 0.03 ng/ml at baseline to 0.53 +/- 0.06 ng/ml at 5 min; p < 0.01) was observed after an allergenic challenge (Dermatophagoides pteronyssinus) causing a fall in FEV1 peaking at 10 min (22 +/- 4 percent). Thus, inhaled PAF may induce airway obstruction and neutropenia in asthmatics without any significant change of plasma histamine level. These results indicate that it is unlikely that lung mast cells or basophils degranulate during PAF-induced bronchoconstriction. [less ▲]

Detailed reference viewed: 7 (1 ULg)
Peer Reviewed
See detailNo increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients.
Paquot, Nicolas ULg; Castillo, M. J.; Lefebvre, Pierre ULg et al

in Journal of Clinical Endocrinology and Metabolism (2000), 85(3), 1316-9

Inhibition of tumor necrosis factor (TNF)-alpha results in a marked increase in insulin sensitivity in obese rodents. We investigated the influence of a TNF antagonist [Ro 45-2081, a recombinant fusion ... [more ▼]

Inhibition of tumor necrosis factor (TNF)-alpha results in a marked increase in insulin sensitivity in obese rodents. We investigated the influence of a TNF antagonist [Ro 45-2081, a recombinant fusion protein that consists of the soluble TNF-receptor (p55) linked to the Fc portion of human IgG1] on insulin sensitivity of patients with android obesity. Seven patients (five women and two men; mean +/- SD age, 41 +/- 4 yr; body mass index, 36.1 +/- 4.7 kg/m2; waist to hip ratio, 0.99 +/- 0.11) were studied (three patients with normal glucose tolerance and four patients with impaired glucose tolerance or mild diabetes; all were hyperinsulinemic). Each patient underwent two consecutive euglycemic hyperinsulinemic glucose-clamp tests: 48 h after injection of placebo and 48 h after a single i.v. injection of 50 mg Ro 45-2081. In both tests, steady-state plasma glucose and insulin levels were similar. Insulin-mediated glucose disposal (2.23 +/- 0.74 vs. 2.38 +/- 0.99 mg/kg(-1) x min(-1)) and glucose metabolic clearance rate (2.28 +/- 0.85 vs. 2.48 +/- 1.03 mL/kg(-1) x min(-1)) were similar after placebo and after the drug. Indirect calorimetry showed no difference in substrate oxidation rates between the two experimental conditions. In conclusion, under the conditions of this study, no improvement in insulin sensitivity was observed in obese insulin-resistant patients following a single i.v. administration of a recombinant TNF receptor: Fc fusion protein. [less ▲]

Detailed reference viewed: 4 (0 ULg)
Full Text
Peer Reviewed
See detailNo influence of 20 and 400 mu T 50 Hz magnetic field exposure on cognitive function in humans
Delhez, Marie; Legros, Jean-Jacques ULg; Crasson, Marion ULg

in Bioelectromagnetics (2004), 25(8), 592-598

The aim of the present study was to investigate cognitive effects of a continuous, vertical extremely low frequency (ELF) magnetic field (MF) of 20 and 400 muT 50 Hz in healthy young men during ... [more ▼]

The aim of the present study was to investigate cognitive effects of a continuous, vertical extremely low frequency (ELF) magnetic field (MF) of 20 and 400 muT 50 Hz in healthy young men during performance on cognitive tests. Thirty-two volunteers (20-30 years old, mean 22.6 +/- 2.2 years) participated in this double blind study. The test protocol consisted of a set of tests: divided attention, flexibility, memory updating, digit span, digit span with articulary suppression, and time perception. The total duration of the exposure was 65 min. Participants were assigned four sessions: three conditions in the helmet (sham exposure, 20 and 400 muT) and one condition out of the helmet (to control the expectancy effect). No effect of MF exposure was observed on performance. Bioelectromagnetics 25:592-598, 2004. (C) 2004 Wiley-Liss, Inc. [less ▲]

Detailed reference viewed: 18 (0 ULg)
Full Text
Peer Reviewed
See detailNo interest for a second close infiltration of platelet-rich plasma to treat upper patellar tendinopathies
Kaux, Jean-François ULg; Croisier, Jean-Louis ULg; Buhler, Frédéric et al

in European Journal of Physical and Rehabilitation Medicine (2014, May), 50(Suppl. 1 to No. 3), 21639-002-

Background: Some clinical series have evaluated the effect of platelet-rich plasma (PRP) in the treatment of jumper’s knee. Although it is possible that a single infiltrative administration may prove to ... [more ▼]

Background: Some clinical series have evaluated the effect of platelet-rich plasma (PRP) in the treatment of jumper’s knee. Although it is possible that a single infiltrative administration may prove to be an effective treatment for this indication, most of the existing studies evaluated the effects of 2 or 3 successive infiltrations. The aim of this study was to evaluate whether 2 infiltrations of PRP proves more effective than a single treatment. Methods: Twenty patients suffering from jumper’s knee for over than 3 months were enrolled into the study and split into two randomized groups (1 or 2 infiltrations of PRP, respectively). The follow-up evaluation consisted of VAS, IKDC and VISA-P scores, along with algometer, isokinetic and ultrasounds evaluations. Results: The concentration of the PRP used for each infiltration was similar in both groups, and contained no red or white cells. Results revealed no difference in treatment efficacy between the groups. Conclusion: The comparison between 1 or 2 infiltrations of PRP did not reveal any difference between the 2 groups after a follow-up period of 3 months. A second closely-timed infiltration of PRP to treat jumper’s knees is not necessary to improve the efficacy of this treatment in the short term. [less ▲]

Detailed reference viewed: 26 (1 ULg)
Full Text
See detailNo Laughing Matter
Maiorano, Diego ULg

Article for general public (2013)

Detailed reference viewed: 49 (1 ULg)
Full Text
Peer Reviewed
See detailNo major month to month variation in free testosterone levels in aging mates. Minor impact on the biological diagnosis of 'andropause'
Tancredi, Annalisa ULg; Reginster, Jean-Yves ULg; Luyckx, Françoise ULg et al

in Psychoneuroendocrinology (2005), 30(7), 638-646

BACKGROUND: The measurement of bioavailable testosterone (BT) or free testosterone (FT) levels is currently considered the gold standard for the diagnosis of androgen deficiency in elderly men. While the ... [more ▼]

BACKGROUND: The measurement of bioavailable testosterone (BT) or free testosterone (FT) levels is currently considered the gold standard for the diagnosis of androgen deficiency in elderly men. While the impact of age on circulating testosterone levels (total, bioavailable and free) has been strongly documented, the existence of seasonal variations in testosterone levels remains debated. OBJECTIVE: We investigated whether seasonal variations in serum calculated free testosterone (cFT) levels may translate into variations in the prevalence of low testosterone levels. Diagnosis was on the basis of biochemical determinations and was cross-checked with the prevalence of clinical signs and symptoms of 'andropause', as assessed by the Androgen Deficiency in Aging Males (ADAM) questionnaire. METHODS: The study recruited 5028 men aged 50 years and over from September 2000 to January 2003. Their serum FT levels were assessed and they completed the French ADAM test. Men were considered eugonadal when cFT was > or =70 ng/l. The ADAM test was scored as described originally. The prevalence of 'andropause', diagnosed by the two methods, was compared throughout the year, on a month by month basis. RESULTS: The percentage of subjects with cFT levels below 70 ng/l increased significantly with age (P<0.001). Serum cFT levels (mean [SD]) varied significantly with the month of sampling (P<0.0001), the highest (88.1 [30.2] ng/l) and lowest (76.9 [28.0] ng/l) mean values occurring in April and in October, respectively. Conversely, the prevalence of testosterone deficiency (cFT<70 ng/l) reached a peak in October (45.7%) and a nadir in April (29.7%). Although the prevalence of 'andropause', based on the ADAM questionnaire, increased significantly with age (P<0.0001), no influence of the month of the year was noticed. CONCLUSIONS: Our results confirm a progressive age-related decline in FT levels. The monthly variations in serum FT values, observed throughout the year, do not show a major seasonal rhythm in elderly community-dwelling males, since the magnitude of the variations (<15%) remains marginal. This slight variation may, however, have an impact on the number of elderly men diagnosed with Partial Androgen Deficiency in Aging Males (PADAM). [less ▲]

Detailed reference viewed: 35 (5 ULg)
See detailThe NO Martian Nightglow observed with the SPICAM UV Spectrometer and comparison with a one-dimensional model.
Cox, Cédric ULg; Saglam, A.; Gérard, Jean-Claude ULg et al

Conference (2007, April)

Observations in the 108-317 nm wavelength range have been performed with the SPICAM ultraviolet spectrometer aboard the Mars Express (MEX) mission. SPICAM has observed the ultraviolet nightglow emission ... [more ▼]

Observations in the 108-317 nm wavelength range have been performed with the SPICAM ultraviolet spectrometer aboard the Mars Express (MEX) mission. SPICAM has observed the ultraviolet nightglow emission in the δ (190-240 nm) and γ (225-270 nm) bands of nitric oxide (Bertaux et al. 2005). This emission arises from the recombination between O(3P) and N(4S) atoms that are produced on the day side to form NO in the night side. We present a summary of the night limb observations performed during the MEX mission. In particular, we describe the variability of the brightness and peak altitude. We find that the altitude of maximum emission varies between 55 and 90 km and the brightness is in the range 0.2 to 4.5 kR. We compare these observations with the results of a chemical-diffusive atmospheric model which solves the continuity equation for O, N(4S) and NO continuity equation using the finite volume method on one dimensional grid. The eddy coefficient, whose value is very uncertain, is a free parameter adjusted to match the observational data. [less ▲]

Detailed reference viewed: 19 (1 ULg)